Baudax Bio
Malvern
About Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $116.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2023)
- Ticker: nasdaq:BXRX
- Website: baudaxbio.com
- Phone: +1 484-395-2440
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/baudax-bio-154535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.